2150 ST. ELZEAR BLVD. WEST, QUEBEC, A8
Bausch Health Companies Inc. Modifies 2023 PSU Awards for Executives
Financial Results, Press Release
Provides Update on RED-C Phase 3 Clinical Trials
Bausch Health to Present at 44th Annual J.P. Morgan Healthcare Conference
Completes Refinancing of Outstanding Term B Loans
Bausch Health Completes $1.6 Billion Exchange Offer for New Notes
Announces Final Results and Expiration of Exchange Offers
Announces Refinancing of Outstanding Term B Loans
FY 2024
Q3
Q2
Q1
FY 2023
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Certificate
Registration of Securities
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Tender Offer Statement by Third Party
Specialized Disclosure Report